Guardian of genome, targeted therapies in non-diabetic, HER2 positive breast cancer patients: Adding new dowels to a dated puzzle — ScienceDaily
“Research in breast cancer has lately allowed to characterize molecular features that have increasingly become the targets for novel therapeutic interventions. …